In vivoprotection of activated Tyr22-dihydrofolate reductase gene-modified canine T lymphocytes from methotrexate
Author:
Affiliation:
1. Clinical Research Division; Fred Hutchinson Cancer Research Center; Seattle; WA; USA
2. Department of Genetics, Cell Biology, and Development; University of Minnesota; Minneapolis; MN; USA
Publisher
Wiley
Subject
Genetics(clinical),Drug Discovery,Genetics,Molecular Biology,Molecular Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/jgm.2713/fullpdf
Reference32 articles.
1. Extended survival of glioblastoma patients after chemoprotective HSC gene therapy;Adair;Sci Transl Med,2012
2. Phase III study comparing methotrexate and tacrolimus (Prograf, FK506) with methotrexate and cyclosporine for graft-versus-host-disease prophylaxis after HLA-identical sibling bone marrow transplantation;Ratanatharathorn;Blood,1998
3. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors;Nash;Blood,2000
4. Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma;Devine;J Clin Oncol,2004
5. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic haematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival;Valcarcel;J Clin Oncol,2008
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Inhibition of methotrexate induced toxicity in the adult rat spleen by adalimumab;Drug and Chemical Toxicology;2022-01-20
2. Hematopoietic Stem Cell Approaches to Cancer;Hematology/Oncology Clinics of North America;2017-10
3. Towards in vivo amplification: Overcoming hurdles in the use of hematopoietic stem cells in transplantation and gene therapy;WORLD J STEM CELLS;2015
4. 211Astatine-Conjugated Monoclonal CD45 Antibody-Based Nonmyeloablative Conditioning for Stem Cell Gene Therapy;Human Gene Therapy;2015-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3